FN1 and neoplasm: Myofibroblasts and fibrosis may then subsequently influence liver pathologies, including the development of HCC through modulation of the tumor microenvironment by fibronectin-mediated cell growth stimulation or cytokine and growth factor release [6, 48, 49].